Halozyme Therapeutics
HALO
#2193
Rank
$6.91 B
Marketcap
$54.30
Share price
-0.82%
Change (1 day)
30.22%
Change (1 year)

Halozyme Therapeutics (HALO) - Total assets

Total assets on the balance sheet as of March 2024 : $1.84 B

According to Halozyme Therapeutics's latest financial reports the company's total assets are $1.84 B. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Halozyme Therapeutics - Total assets on balance sheet (from 2002 to 2024)

Total assets by year

Year Total assets Change
2023-12-31$1.73 B-5.88%
2022-12-31$1.84 B66.74%
2021-12-31$1.10 B90.44%
2020-12-31$0.57 B2.48%
2019-12-31$0.56 B28.54%
2018-12-31$0.44 B-15.33%
2017-12-31$0.51 B98.82%
2016-12-31$0.26 B43.86%
2015-12-31$0.18 B9.53%
2014-12-31$0.16 B63.05%
2013-12-31$0.10 B-24.45%
2012-12-31$0.13 B104.88%
2011-12-31$65.75 M-28.01%
2010-12-31$91.34 M18.4%
2009-12-31$77.14 M0.77%
2008-12-31$76.56 M-26%
2007-12-31$0.10 B124.47%
2006-12-31$46.09 M124.72%
2005-12-31$20.51 M25.03%
2004-12-31$16.4 M2434.38%
2003-12-31$0.64 M180.7%
2002-12-31$0.23 M782.54%
2001-12-31$0.02 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
$0.48 B-73.89%๐Ÿ‡บ๐Ÿ‡ธ USA
$63.94 B 3,372.30%๐Ÿ‡บ๐Ÿ‡ธ USA
$27.78 B 1,408.96%๐Ÿ‡บ๐Ÿ‡ธ USA
$221.09 B 11,906.05%๐Ÿ‡บ๐Ÿ‡ธ USA
$139.81 B 7,492.38%๐Ÿ‡ซ๐Ÿ‡ท France
$171.96 B 9,238.21%๐Ÿ‡บ๐Ÿ‡ธ USA